logo
Select company
Select metric
$ -48.6MConsolidated Income
VS
Market
20
Sector
39
Industry
51
History
22
$ 4.15Close
$ 4.04 - $ 16.8 52-Week Range
Ticker Information

Ticker

VRCA

Company Name

VERRICA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VERRICA PHARMACEUTICALS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VRCA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -48.6M
3/31/2025$ -65.99M
12/31/2024$ -76.58M
9/30/2024$ -84.99M
6/30/2024$ -86.93M
3/31/2024$ -80.74M
12/31/2023$ -67M
9/30/2023$ -48.31M
6/30/2023$ -23.43M
3/31/2023$ -22.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VERRICA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -37.35M.
  • Over the past 5 years, VERRICA PHARMACEUTICALS INC's average Cons. Inc. has been $ -48.25M.
  • The median Cons. Inc. for VERRICA PHARMACEUTICALS INC during this period was $ -41.81M
  • VERRICA PHARMACEUTICALS INC reached its highest Cons. Inc. over the past 5 years at $ -22.61M.
  • The lowest Cons. Inc. recorded by VERRICA PHARMACEUTICALS INC in the same timeframe $ -86.93M

VERRICA PHARMACEUTICALS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
IRD : OPUS GENETICS INC $ -58.27MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -69.5MEQ : EQUILLIUM INC $ -20.19MHYFT : MINDWALK HOLDINGS CORP $ -21.16MXLO : XILIO THERAPEUTICS INC $ -56.22MCUE : CUE BIOPHARMA INC $ -38.9MSRZN : SURROZEN INC $ -16.7MOVID : OVID THERAPEUTICS INC $ -38.18MWHWK : WHITEHAWK THERAPEUTICS INC $ -10.42MPSTV : PLUS THERAPEUTICS INC $ -19.03M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

VRCA - Consolidated Income, Last 5 years

$ -86.93M

Minimum

Jun 30, 2024

$ -22.61M

Maximum

Mar 31, 2023

$ -48.25M

Average

$ -41.81M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M